downgraded: Jefferies Recommends Landos Biopharma Inc (NASDAQ:LABP) Stock to “a Hold”
Jefferies lowered the price target for the Landos Biopharma Inc (NASDAQ:LABP) stock from “a Buy” to “a Hold”. The rating was released on April 12, 2022, according to finviz. We previously noted in another research note published on November 16, 2021 by SVB Leerink that downgraded the stock from an Outperform to a Mkt perform […]